• Integra LifeSciences named board chairman Stuart M. Essig president and CEO, effective May 1, 2026, replacing Mojdeh Poul.
• Essig will remain chairman; he previously led Integra as CEO from 1997 to early 2012, serving as president from 1997 to 2010.
• Michael McBreen, executive vice president and president of Codman Specialty Surgical, was appointed chief commercial officer in a newly created role.
• Global commercial organization across both divisions will report to McBreen, consolidating customer-facing execution under one leader.
• Board does not plan to run a CEO search, framing Essig appointment as permanent.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Integra LifeSciences Holdings Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605050600PRIMZONEFULLFEED9712939) on May 05, 2026, and is solely responsible for the information contained therein.